Company Filing History:
Years Active: 2012
Title: Jord Lord - Innovator in Pharmaceutical Compounds
Introduction
Jord Lord is a notable inventor based in Poughkeepsie, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Jord Lord holds a patent for "Pyrazole compounds as CCR1 antagonists." This patent discloses compounds that block the interaction of CCR1 and its ligands. These compounds are useful for treating various diseases and disorders mediated by CCR1 activity, including autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The patent also includes pharmaceutical compositions comprising these compounds, methods for their use in treatment, and processes for preparing these compounds and their intermediates.
Career Highlights
Jord Lord is associated with Boehringer Ingelheim International GmbH, where he applies his expertise in pharmaceutical innovation. His work focuses on developing new therapeutic options that can improve patient outcomes in various medical conditions.
Collaborations
Jord collaborates with talented professionals in his field, including Brian Nicholas Cook and Christian Harcken. These collaborations enhance the research and development efforts at Boehringer Ingelheim.
Conclusion
Jord Lord's innovative work in pharmaceutical compounds demonstrates his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of autoimmune diseases and improve the quality of life for many patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.